RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: autoimmune disease of gastrointestinal tract
Accession: DOID:0060031
browse the term
Definition: An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the gastrointestinal tract. (DO)
Synonyms: narrow_synonym: IMMUNODEFICIENCY AND AUTOIMMUNE ENTEROCOLOPATHY
G
Nfat5
nuclear factor of activated T-cells 5
ISO
ClinVar Annotator: match by term: Immunodeficiency and Autoimmune Enterocolopathy
ClinVar
PMID:28492532
NCBI chr19:35,199,737...35,286,675
Ensembl chr19:35,199,016...35,286,675
G
Atp4b
ATPase H+/K+ transporting subunit beta
ISO
RGD
PMID:8393475 PMID:7517707
RGD:14696740 , RGD:14696746
NCBI chr16:76,144,150...76,153,063
Ensembl chr16:76,144,150...76,153,063
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:19301087
RGD:5686833
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Aldob
aldolase, fructose-bisphosphate B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16115720
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
G
C1s
complement C1s
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11390518
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
G
Ccl2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Cd274
CD274 molecule
ISO
RGD
PMID:19781375
RGD:41412171
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
DNA:SNPs:exons:49A>G (rs231775), CT60 C > T(rs3087243)(human)
RGD
PMID:30320190
RGD:14398726
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cyp2d3
cytochrome P450, family 2, subfamily d, polypeptide 3
ISO
RGD
PMID:3186722
RGD:7207226
NCBI chr 7:113,917,711...113,922,068
Ensembl chr 7:113,908,947...113,922,084
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
protein:increased expression:serum:
RGD
PMID:10435724
RGD:11353781
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Dnase1
deoxyribonuclease 1
ISO
protein:decreased activity:serum (human)
RGD
PMID:28263100
RGD:38500241
NCBI chr10:11,498,930...11,505,151
Ensembl chr10:11,498,931...11,501,869
G
F2
coagulation factor II, thrombin
disease_progression
ISO
RGD
PMID:21711423 PMID:20821236
RGD:5147750 , RGD:5147775
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fas
Fas cell surface death receptor
treatment
ISO
protein:increased expression:lymphocyte:
RGD
PMID:28551553 PMID:26429926
RGD:14700710 , RGD:14700711
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
treatment
ISO
RGD
PMID:28551553
RGD:14700710
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Hras
HRas proto-oncogene, GTPase
ISO
human gene in a mouse model
RGD
PMID:9195373
RGD:14694814
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il2
interleukin 2
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21227906 PMID:29233784 PMID:29323192
RGD:14747042 , RGD:14747037
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il21
interleukin 21
exacerbates
ISO
protein:increased expression:blood serum, peripheral blood mononuclear cell (human)
RGD
PMID:27386263
RGD:127285554
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
G
Il22
interleukin 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
G
Il4
interleukin 4
treatment susceptibility
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum: DNA:SNPs:promoter:-590C>T,-33T>C (human)
CTD RGD
PMID:21227906 PMID:30034292 PMID:30034292 PMID:26735262
RGD:14696683 , RGD:14696683 , RGD:14696677
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il9
interleukin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr17:8,111,772...8,114,895
Ensembl chr17:8,111,772...8,114,895
G
Lep
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Mir155
microRNA 155
treatment
ISO
RGD
PMID:30290123 PMID:29420849
RGD:21081535 , RGD:21409750
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir223
microRNA 223
treatment
ISO
RGD
PMID:31826604 PMID:29145157
RGD:21408546 , RGD:21408563
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Pdcd1
programmed cell death 1
ISO
RGD
PMID:23869988 PMID:19781375
RGD:40818236 , RGD:41412171
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
Pdcd1lg2
programmed cell death 1 ligand 2
ISO
RGD
PMID:19781375
RGD:41412171
NCBI chr 1:227,158,941...227,223,938
Ensembl chr 1:227,158,941...227,223,938
G
Pdia3
protein disulfide isomerase family A, member 3
IDA ISO
RGD
PMID:20208391 PMID:20208391
RGD:9999172 , RGD:9999172
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
G
RT1-Bb
RT1 class II, locus Bb
ISO
DNA:polymorphism (human)
RGD
PMID:20007077 PMID:17050030
RGD:5147584 , RGD:5147634
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
susceptibility
ISO
DNA:polymorphisms (human) DNA:polymorphisms: :multiple (human) DNA:polymorphism (human)
RGD
PMID:17050030 PMID:10573514 PMID:11182227 PMID:15763345
RGD:5147634 , RGD:5147856 , RGD:5147810 , RGD:5147652
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
susceptibility
ISO
DNA:SNP, polymorphism:3' utr, :g.33087030G>A, HLA-DPB1*04:05 (rs9277534) (human)
RGD
PMID:30093645
RGD:150429797
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
Stat4
signal transducer and activator of transcription 4
susceptibility
ISO
DNA:SNPs: intron 3, intron: (rs7574865, rs7582694) (human)
RGD
PMID:28977835
RGD:25671419
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21227906
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:serum (human)
RGD
PMID:9047083
RGD:14995307
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vdr
vitamin D receptor
susceptibility
ISO
DNA:polymorphism: :
GAD RGD
PMID:15118671 PMID:15683428
RGD:1331525 , RGD:14402024
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:plasma:
RGD
PMID:26615570
RGD:11538286
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Zfhx3
zinc finger homeobox 3
ISO
protein:increased expression:blood serum (human)
RGD
PMID:20534899
RGD:151361169
NCBI chr19:36,257,196...36,886,104
Ensembl chr19:36,630,254...36,881,771
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Apob
apolipoprotein B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Apoc3
apolipoprotein C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
G
Asah2
N-acylsphingosine amidohydrolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 1:229,865,662...229,973,253
Ensembl chr 1:229,865,662...229,939,162
G
Bach2
BTB domain and CNC homolog 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr 5:46,632,338...46,982,676
Ensembl chr 5:46,638,317...46,977,877
G
Capn8
calpain 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr13:94,252,218...94,316,146
Ensembl chr13:94,253,054...94,316,146
G
Ccr4
C-C motif chemokine receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
G
Cd14
CD14 molecule
ISO
associated with Diabetes Mellitus, Insulin-Dependent;DNA:SNP:promoter:
RGD
PMID:18728522
RGD:2314152
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd36
CD36 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd80
Cd80 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Celiac disease, susceptibility to, 3 | ClinVar Annotator: match by term: GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 3 DNA:SNPs,haplotype: :rs231770,rs231775(human)
OMIM CTD ClinVar RGD
PMID:8817351 PMID:9259273 PMID:9398726 PMID:10189842 PMID:10475192 PMID:11098935 PMID:11158025 PMID:12724780 PMID:15138458 PMID:15199380 PMID:15301861 PMID:15688186 PMID:24033266 PMID:25741868 PMID:26884280 PMID:27102614 PMID:27577878 PMID:28492532 PMID:30377434 PMID:30940614 PMID:10189842 PMID:19020530 More...
RGD:1300387 , RGD:11344917
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl11
C-X-C motif chemokine ligand 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Ets1
ETS proto-oncogene 1, transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:23556408
RGD:7387257
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fcgr3a
Fc gamma receptor 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
G
Gbp5
guanylate binding protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 2:231,237,748...231,257,071
Ensembl chr 2:231,237,748...231,257,061
G
Icos
inducible T-cell co-stimulator
susceptibility
ISO
DNA:SNP,haplotype: :rs10932037(human)
RGD
PMID:19020530
RGD:11344917
NCBI chr 9:62,368,075...62,406,900
Ensembl chr 9:62,383,832...62,405,672
G
Icoslg
inducible T-cell co-stimulator ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr20:10,600,420...10,610,718
Ensembl chr20:10,600,420...10,610,703
G
Ifi27
interferon, alpha-inducible protein 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:30097691 PMID:26440733
RGD:14974259
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
ISO
RGD
PMID:27545437
RGD:14975156
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il15
interleukin 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23269601
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il21
interleukin 21
susceptibility
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (human)
CTD RGD
PMID:17558408 PMID:22077623
RGD:127285362
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
G
Il23r
interleukin 23 receptor
susceptibility
ISO
DNA:SNP:cds:p.R381Q(rs11209026)(human)
RGD
PMID:19175939 PMID:18368064
RGD:8549604 , RGD:8549631
NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
G
Il6
interleukin 6
ISO
associated with Diabetes Mellitus, Insulin-Dependent; DNA:polymorphism:promoter:-174G>C (human)
RGD
PMID:18692934
RGD:2307292
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Lcn2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lpl
lipoprotein lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lrat
lecithin retinol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
G
Mmp12
matrix metallopeptidase 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
G
Mmp3
matrix metallopeptidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Myo9b
myosin IXb
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Celiac disease, susceptibility to, 4 | ClinVar Annotator: match by term: GLUTEN-SENSITIVE ENTEROPATHY, SUSCEPTIBILITY TO, 4
CTD ClinVar
PMID:15822038 PMID:16282976 PMID:25741868 PMID:28492532
NCBI chr16:17,945,379...18,030,114
Ensembl chr16:17,945,448...18,030,126
G
Pck1
phosphoenolpyruvate carboxykinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Piwil2
piwi-like RNA-mediated gene silencing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
G
Pon1
paraoxonase 1
ISO
mRNA:decreased expression:duodenum (human)
RGD
PMID:17664137
RGD:5509924
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Pon3
paraoxonase 3
ISO
mRNA:decreased expression:duodenum (human)
RGD
PMID:17664137
RGD:5509924
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
associated with Diabetes Mellitus, Insulin-Dependent CTD Direct Evidence: marker/mechanism associated with Down Syndrome;DNA:polymorphism (human) associated with Thyroiditis, Autoimmune;DNA:polymorphism (human) DNA:polymorphisms (human)
CTD OMIM RGD
PMID:16567828 PMID:11426458 PMID:11713456 PMID:18509540 PMID:19494267 PMID:17919990 More...
RGD:2301813 , RGD:5147854 , RGD:5147808 , RGD:5147791 , RGD:5147789 , RGD:5147625
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
DNA:polymorphism (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms associated with Down Syndrome;DNA:polymorphisms, haplotype:HLA-DQB1*0201 (human) associated with Thyroiditis, Autoimmune;DNA:polymorphisms, haplotype:HLA-DQB1*02 (human) DNA:polymorphisms, haplotypes:multiple (human)
OMIM CTD RGD
PMID:17919990 PMID:29793442 PMID:30013750 PMID:28247576 PMID:11426458 PMID:11713456 PMID:18509540 PMID:19494267 More...
RGD:5147625 , RGD:14974234 , RGD:14928328 , RGD:14865008 , RGD:5147854 , RGD:5147808 , RGD:5147791 , RGD:5147789
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
ISO
DNA:polymorphisms (human)
RGD
PMID:12404952
RGD:5147803
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17956852
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
Runx3
RUNX family transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
G
S100a9
S100 calcium binding protein A9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Slc6a14
solute carrier family 6 member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
G
Soat2
sterol O-acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:133,281,818...133,294,915
G
Tff1
trefoil factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Tfrc
transferrin receptor
ISO
mRNA,protein:increased expression:duodenum:
RGD
PMID:15054143
RGD:11062102
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgm2
transglutaminase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17190764
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Themis
thymocyte selection associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr 1:16,433,906...16,623,889
Ensembl chr 1:16,432,631...16,664,329
G
Tnfrsf14
TNF receptor superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr 5:165,486,069...165,494,421
Ensembl chr 5:165,484,262...165,493,703
G
Tnfrsf9
TNF receptor superfamily member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Ubd
ubiquitin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Ugt1a5
UDP glucuronosyltransferase family 1 member A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Upb1
beta-ureidopropionase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr20:13,217,252...13,243,590
Ensembl chr20:13,217,258...13,243,590
G
Vnn1
vanin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30097691
NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
G
Zmiz1
zinc finger, MIZ-type containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20190752
NCBI chr16:1,027,083...1,232,616
Ensembl chr16:1,027,325...1,232,597
G
Tjp2
tight junction protein 2
ISO
ClinVar Annotator: match by term: Familial primary biliary cirrhosis
ClinVar
PMID:25741868 PMID:28492532 PMID:32439973
NCBI chr 1:221,709,745...221,838,291
Ensembl chr 1:221,709,745...221,838,295
G
Utp4
UTP4 small subunit processome component
ISO
ClinVar Annotator: match by term: Hereditary North American Indian childhood cirrhosis
ClinVar
PMID:9536098 PMID:12417987 PMID:16225863 PMID:17576681 PMID:19732766 PMID:20385600 PMID:22916032 PMID:24123366 PMID:25741868 PMID:27535533 PMID:28492532 More...
NCBI chr19:34,790,962...34,820,558
Ensembl chr19:34,792,457...34,820,550
G
Abca1
ATP binding cassette subfamily A member 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:28660384
RGD:21203516
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abcb4
ATP binding cassette subfamily B member 4
treatment disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype, diplotype: : rs31658, rs31672,rs1149222(human)
CTD RGD
PMID:20040336 PMID:30682444 PMID:21209952 PMID:18671305
RGD:153297773 , RGD:14694982
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcc2
ATP binding cassette subfamily C member 2
ISO IEP
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver
CTD RGD
PMID:15542527 PMID:15770136
RGD:14700810
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcg2
ATP binding cassette subfamily G member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542527
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Ace
angiotensin I converting enzyme
IEP
mRNA:increased expression:liver
RGD
PMID:19389807
RGD:2325226
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
IEP
mRNA, protein:increased expression:liver
RGD
PMID:17532087
RGD:9685452
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Agt
angiotensinogen
IEP
protein:increased expression:plasma
RGD
PMID:17532087
RGD:9685452
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aqp4
aquaporin 4
IEP
RGD
PMID:20451280
RGD:5148030
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Car1
carbonic anhydrase 1
ISO
RGD
PMID:12806141
RGD:408425977
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
G
Car2
carbonic anhydrase 2
ISO
RGD
PMID:12806141
RGD:408425977
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Ccl5
C-C motif chemokine ligand 5
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver:
CTD RGD
PMID:12126966 PMID:15770052
RGD:14995336
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccn2
cellular communication network factor 2
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:19371232
RGD:2314517
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Cd14
CD14 molecule
disease_progression
ISO
protein:increased expression:liver (human)
RGD
PMID:21275501
RGD:407420272
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd3d
CD3 delta subunit of T-cell receptor complex
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 8:45,287,803...45,293,342
Ensembl chr 8:45,288,749...45,301,809
G
Cd68
Cd68 molecule
disease_progression
ISO
protein:increased expression:liver (human)
RGD
PMID:21275501
RGD:407420272
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cd80
Cd80 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cdh5
cadherin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
ISO
protein:increased expression:epithelial cell:
RGD
PMID:18456456
RGD:8662434
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cenpb
centromere protein B
ISO
RGD
PMID:8911074
RGD:27226708
NCBI chr 3:118,396,987...118,399,780
Ensembl chr 3:118,388,546...118,400,470
G
Clec16a
C-type lectin domain containing 16A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr10:4,927,799...5,123,749
Ensembl chr10:4,928,030...5,123,578
G
Col1a1
collagen type I alpha 1 chain
treatment
IEP
RGD
PMID:20056896
RGD:8552731
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Cpeb1
cytoplasmic polyadenylation element binding protein 1
IEP
protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr 1:135,300,048...135,407,688
Ensembl chr 1:135,300,461...135,409,760
G
Cpeb4
cytoplasmic polyadenylation element binding protein 4
ISO
protein:increased expression:liver
RGD
PMID:26627607
RGD:11528851
NCBI chr10:15,717,794...15,780,482
Ensembl chr10:15,717,794...15,780,603
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility disease_progression no_association
ISO
autoimmune biliary cirrhosis; DNA:SNP:CDS:49A>G, significant association with G allele (p<0.0002) (human) DNA:SNP:CDS:60G>A(rs3087243)(human) DNA:SNPs: :rs231775, rs3087243, rs231725 (human) DNA:SNP:CDS:49A>G(human)
RGD
PMID:10782900 PMID:16584111 PMID:21594562 PMID:17482523
RGD:2301998 , RGD:14398744 , RGD:14398743 , RGD:14398725
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cxcr5
C-X-C motif chemokine receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 8:44,842,098...44,858,425
Ensembl chr 8:44,843,413...44,857,893
G
Cygb
cytoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
G
Dag1
dystroglycan 1
IEP
mRNA:increased expression:liver
RGD
PMID:12177244
RGD:2314895
NCBI chr 8:108,890,926...108,955,611
Ensembl chr 8:108,890,929...108,952,325
G
Dennd1b
DENN domain containing 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr13:50,545,324...50,772,922
Ensembl chr13:50,545,836...50,770,601
G
Dnase1
deoxyribonuclease 1
ISO
protein:decreased activity:serum (human)
RGD
PMID:28263100
RGD:38500241
NCBI chr10:11,498,930...11,505,151
Ensembl chr10:11,498,931...11,501,869
G
Entpd2
ectonucleoside triphosphate diphosphohydrolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15651265 PMID:15651265
RGD:9685530
NCBI chr 3:8,213,575...8,219,094
Ensembl chr 3:8,213,663...8,226,866
G
Fas
Fas cell surface death receptor
ISO
protein:increased expression:lymphocyte:
RGD
PMID:26429926
RGD:14700711
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Foxp3
forkhead box P3
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Gch1
GTP cyclohydrolase 1
treatment
IEP
RGD
PMID:20132096
RGD:329970291
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Hamp
hepcidin antimicrobial peptide
treatment
ISO IEP
mRNA:decreased expression:liver
RGD
PMID:19652645 PMID:23704825
RGD:11041639 , RGD:11041732
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Hhip
Hedgehog-interacting protein
IEP
mRNA:decreased expression:
RGD
PMID:18375471
RGD:11552599
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
G
Hif1a
hypoxia inducible factor 1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22271822
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
IEP
mRNA, protein:increased expression:liver, lung
RGD
PMID:12114196
RGD:625603
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Icam1
intercellular adhesion molecule 1
treatment
ISO
associated with Graft vs Host Disease; protein:increased expression:serum:
RGD
PMID:10051478 PMID:11280567
RGD:11520783 , RGD:597000690
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Ifng
interferon gamma
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igfbp1
insulin-like growth factor binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Il10
interleukin 10
ISO
mRNA:increased expression:liver
RGD
PMID:17158635
RGD:38501106
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il12a
interleukin 12A
susceptibility treatment
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype: :rs6441286, rs574808(human) DNA:SNP: :rs62270414(human) DNA:SNPs:enhancer:rs4679868, rs6441286, rs666251(human)
CTD RGD
PMID:20639880 PMID:19458352 PMID:23433321 PMID:27175695
RGD:25440500 , RGD:25440498 , RGD:25440489
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
Il12b
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639880
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il12rb1
interleukin 12 receptor subunit beta 1
susceptibility
IEP
RNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:23910013
RGD:14700865
NCBI chr16:18,620,228...18,633,207
Ensembl chr16:18,620,770...18,632,769
G
Il1b
interleukin 1 beta
disease_progression
ISO
protein:increased expression:blood serum (human)
RGD
PMID:21275501
RGD:407420272
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il4
interleukin 4
treatment
IEP
RGD
PMID:20442198
RGD:7829828
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
disease_progression
ISO
protein:increased expression:blood serum (human)
RGD
PMID:21275501
RGD:407420272
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il7r
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Jak2
Janus kinase 2
treatment
IMP
RGD
PMID:24619965
RGD:10403061
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Keap1
Kelch-like ECH-associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Krt18
keratin 18
severity
ISO
protein:increased expression:serum (human)
RGD
PMID:26110613
RGD:18337483
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
G
Krt7
keratin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21681009
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Lbr
lamin B receptor
ISO
RGD
PMID:8550049
RGD:9588625
NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017
G
Lep
leptin
ISO
protein:decreased expression:serum:
RGD
PMID:16093869
RGD:10411894
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lepr
leptin receptor
ISO
protein:increased expression:serum:
RGD
PMID:16093869
RGD:10411894
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Lox
lysyl oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16023247
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Loxl2
lysyl oxidase-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16023247
NCBI chr15:44,683,449...44,773,067
Ensembl chr15:44,683,880...44,773,067
G
Map3k14
mitogen-activated protein kinase kinase kinase 14
ISS
OMIM:109720 | OMIM:613007 | OMIM:613008 | OMIM:614220 | OMIM:614221
MouseDO
NCBI chr10:88,165,349...88,215,558
Ensembl chr10:88,165,351...88,215,523
G
Mapk14
mitogen activated protein kinase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mas1
MAS1 proto-oncogene, G protein-coupled receptor
IEP
RGD
PMID:17532087
RGD:9685452
NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709
G
Met
MET proto-oncogene, receptor tyrosine kinase
severity
ISO
RGD
PMID:19208365
RGD:14694826
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mir21
microRNA 21
severity
ISO
RGD
PMID:28886078
RGD:21408577
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mir223
microRNA 223
severity
ISO
RGD
PMID:28886078
RGD:21408577
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Mmel1
membrane metallo-endopeptidase-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639879
NCBI chr 5:165,431,278...165,461,716
Ensembl chr 5:165,431,343...165,461,716
G
Mmp13
matrix metallopeptidase 13
treatment
IEP
RGD
PMID:20056896
RGD:8552731
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp2
matrix metallopeptidase 2
treatment
IEP
RGD
PMID:20056896
RGD:8552731
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp3
matrix metallopeptidase 3
treatment
IEP
RGD
PMID:20056896
RGD:8552731
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
treatment
IEP
RGD
PMID:20056896
RGD:8552731
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Msn
moesin
IDA
protein:increased phosphorylation:liver, blood vessel:
RGD
PMID:16492715
RGD:2298879
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
G
Muc2
mucin 2, oligomeric mucus/gel-forming
ISO
RGD
PMID:18507686
RGD:2324885
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nos2
nitric oxide synthase 2
IEP ISO
protein:increased expression, increased activity:brain (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:30026087 PMID:21903766
RGD:5509055
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:30026087 PMID:20132096
RGD:329970291
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
susceptibility
ISO
mRNA,protein:decreased expression:liver (human)
RGD
PMID:29968724
RGD:14928336
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
mRNA:altered expression:leukocyte, mononuclear
RGD
PMID:15635817
RGD:4892607
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nsa2
NSA2 ribosome biogenesis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr 2:28,443,142...28,449,393
Ensembl chr 2:28,441,269...28,449,388
G
Nup62
nucleoporin 62
severity
ISO
RGD
PMID:12753810
RGD:9831196
NCBI chr 1:95,298,995...95,314,902
Ensembl chr 1:95,295,526...95,315,174
G
Pde5a
phosphodiesterase 5A
IMP
RGD
PMID:17610866
RGD:2314466
NCBI chr 2:210,858,515...211,003,480
Ensembl chr 2:210,858,063...210,999,701
G
Ppargc1a
PPARG coactivator 1 alpha
IEP
mRNA, protein:decreased expression:liver
RGD
PMID:
RGD:6484526
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Rela
RELA proto-oncogene, NF-kB subunit
disease_progression
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
CTD RGD
PMID:30026087 PMID:21275501
RGD:407420272
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Ren
renin
IEP
protein:increased activity:plasma (rat)
RGD
PMID:22266601
RGD:6892690
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Rhoa
ras homolog family member A
IEP
mRNA, protein:increased expression:liver
RGD
PMID:16492715
RGD:2298879
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
Rock2
Rho-associated coiled-coil containing protein kinase 2
IEP
mRNA, protein:increased expression:liver
RGD
PMID:16492715
RGD:2298879
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
G
Rps6kb1
ribosomal protein S6 kinase B1
IEP
protein:increased expression, increased phosphorylation:liver
RGD
PMID:15769867
RGD:1642977
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:15713222
RGD:14401562
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
Sell
selectin L
ISO
protein:increased expression:serum:
RGD
PMID:11280567
RGD:597000690
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Slc4a2
solute carrier family 4 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18188457
NCBI chr 4:10,736,419...10,754,407
Ensembl chr 4:10,736,425...10,752,965
G
Slc51a
solute carrier family 51 member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16423920
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
G
Slc51b
SLC51 subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16423920
NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
G
Slco1a1
solute carrier organic anion transporter family, member 1a1
IEP
protein:decreased expression:liver
RGD
PMID:15770136
RGD:14700810
NCBI chr 4:174,877,045...174,950,900
Ensembl chr 4:174,876,593...174,950,873
G
Slco1c1
solute carrier organic anion transporter family, member 1c1
IEP
protein:decreased expression:liver
RGD
PMID:15770136
RGD:14700810
NCBI chr 4:174,466,621...174,513,290
Ensembl chr 4:174,466,631...174,513,289
G
Sod2
superoxide dismutase 2
ISO
protein:increased expression:serum
RGD
PMID:1682406
RGD:2317411
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Spib
Spi-B transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20639880
NCBI chr 1:95,018,939...95,024,804
Ensembl chr 1:95,018,947...95,024,780
G
Spint1
serine peptidase inhibitor, Kunitz type 1
ISO
mRNA:increased expression:liver:
RGD
PMID:21898507
RGD:10043111
NCBI chr 3:106,231,082...106,244,121
Ensembl chr 3:106,231,444...106,244,119
G
Spint2
serine peptidase inhibitor, Kunitz type, 2
ISO
mRNA:increased expression:liver:
RGD
PMID:21898507
RGD:10043111
NCBI chr 1:84,558,159...84,580,616
Ensembl chr 1:84,558,166...84,580,616
G
Stat4
signal transducer and activator of transcription 4
susceptibility no_association
ISO
DNA:SNPs, haplotypes:multiple CTD Direct Evidence: marker/mechanism associated with Crohn���s disease; DNA:SNP:intron: (rs7574865) (human) DNA:SNP: intron: (rs7574865) (human) DNA:SNPs:3'utr: (rs7574865, rs8179673, rs10181656) (human)
CTD RGD
PMID:21399635 PMID:24648611 PMID:26084578 PMID:28395724 PMID:24648611
RGD:25671415 , RGD:25671421 , RGD:25671416 , RGD:25671415
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026087
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tjp2
tight junction protein 2
ISO
ClinVar Annotator: match by term: Primary biliary cirrhosis
ClinVar
PMID:25741868 PMID:28492532 PMID:32439973
NCBI chr 1:221,709,745...221,838,291
Ensembl chr 1:221,709,745...221,838,295
G
Tlr9
toll-like receptor 9
ISO
protein:increased expression:liver, peripheral blood mononuclear cell (human)
RGD
PMID:23026026
RGD:18337477
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
disease_progression
ISO
protein:increased expression:serum (human) protein:increased expression:blood serum(human) mRNA:increased expression:liver
RGD
PMID:9047083 PMID:21275501 PMID:17158635
RGD:14995307 , RGD:407420272 , RGD:38501106
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399635
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tyk2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22961000
NCBI chr 8:19,641,881...19,667,157
Ensembl chr 8:19,641,884...19,667,044
G
Ubd
ubiquitin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422935
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Utp4
UTP4 small subunit processome component
ISO
North American Indian childhood cirrhosis, OMIM:604901, R565W
RGD
PMID:12417987
RGD:1600653
NCBI chr19:34,790,962...34,820,558
Ensembl chr19:34,792,457...34,820,550
G
Vdr
vitamin D receptor
susceptibility
ISO
DNA:polymorphism: : DNA:SNP: :
GAD RGD
PMID:15118671 PMID:15683428 PMID:19376604
RGD:1331525 , RGD:14402024 , RGD:14401750
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
IEP ISO
protein:increased expression:liver protein:increased expression:plasma:
RGD
PMID:26627607 PMID:26615570
RGD:11528851 , RGD:11538286
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Zc3h12a
zinc finger CCCH type containing 12A
ISS
OMIM:109720 | OMIM:613007 | OMIM:613008 | OMIM:614220 | OMIM:614221
MouseDO
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Il12rb2
interleukin 12 receptor subunit beta 2
ISO
ClinVar Annotator: match by term: IL12RB2-related condition
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 4:96,426,396...96,515,251
Ensembl chr 4:96,426,842...96,515,289
G
Lbr
lamin B receptor
ISO
ClinVar Annotator: match by term: PRIMARY BILIARY CIRRHOSIS, SCLERODERMA, RAYNAUD DISEASE, AND TELANGIECTASIA | ClinVar Annotator: match by term: Reynolds syndrome
OMIM ClinVar
PMID:18382993 PMID:20522425 PMID:23824842 PMID:24033266 PMID:25348816 PMID:25741868 PMID:26467025 PMID:28492532 PMID:30448303 PMID:32827848 PMID:34567078 PMID:36307859 More...
NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017
G
Abcb1a
ATP binding cassette subfamily B member 1A
susceptibility
ISO
RGD
PMID:15505619
RGD:1598568
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
ISO
mRNA:decreased expression:colonic mucosa
RGD
PMID:21987487
RGD:7241281
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
G
Adcy7
adenylate cyclase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28067910
NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:16432373
RGD:5686726
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adrb2
adrenoceptor beta 2
IEP
protein:decreased expression:large intestine mucosa,spleen
RGD
PMID:22772914
RGD:7175063
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alox12
arachidonate 12-lipoxygenase, 12S type
ISO
protein:increased expression:large intestine epithelium
RGD
PMID:7679252
RGD:5509621
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
G
Alpi
alkaline phosphatase, intestinal
ISO
protein:decreased expression:colonic mucosa
RGD
PMID:22783049
RGD:14367879
NCBI chr 9:87,773,411...87,776,877
Ensembl chr 9:87,773,411...87,776,877
G
Apln
apelin
ISO
protein:increased expression:intestine
RGD
PMID:17391779
RGD:1626177
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
G
Apoa4
apolipoprotein A4
severity
ISO
DNA:missense mutation:cds:p.Q360H (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:35999755 PMID:17206692
RGD:5685660
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Aqp7
aquaporin 7
severity
ISO
mRNA, protein:decreased expression:colon
RGD
PMID:15338270
RGD:1626292
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
G
Arpc2
actin related protein 2/3 complex, subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18836448
NCBI chr 9:75,820,782...75,851,471
Ensembl chr 9:75,820,770...75,851,471
G
Bcl6
BCL6, transcription repressor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:38164749
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
G
Brinp3
BMP/retinoic acid inducible neural specific 3
ISO
mRNA,protein:decreased expression:intestine
RGD
PMID:25171508
RGD:14398484
NCBI chr13:58,413,883...58,846,828
Ensembl chr13:58,413,883...58,846,770
G
Btnl2
butyrophilin-like 2
susceptibility
ISO
DNA:SNPs: : rs2294881,rs9268480,rs2076523(human)
RGD
PMID:19659809
RGD:9685032
NCBI chr20:4,490,169...4,504,002
Ensembl chr20:4,489,517...4,503,341
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Card9
caspase recruitment domain family, member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 3:9,171,814...9,180,310
Ensembl chr 3:9,171,815...9,180,237
G
Casp3
caspase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccl20
C-C motif chemokine ligand 20
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16306769 PMID:21887805
RGD:7488892
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
Ccl7
C-C motif chemokine ligand 7
ISO
protein:increased expression:colon
RGD
PMID:10433925
RGD:6483784
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccny
cyclin Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr17:57,385,002...57,512,860
Ensembl chr17:57,384,176...57,522,378
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21077277
RGD:6892920
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr6
C-C motif chemokine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16306769
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
G
Cd40
CD40 molecule
ISO
protein:increased expression:intestine, epithelial cell
RGD
PMID:20133813
RGD:5490590
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh3
cadherin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
disease_progression
ISO
RGD
PMID:15743319
RGD:8662406
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cfb
complement factor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
ISO
mRNA:increased expression:intestine:
RGD
PMID:27051591
RGD:151667910
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
G
Col18a1
collagen type XVIII alpha 1 chain
IEP
Protein:increased expression:large intestine mucosa
RGD
PMID:17011522
RGD:1600887
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
G
Col1a1
collagen type I alpha 1 chain
ISO
RGD
PMID:17939044
RGD:5688304
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col6a3
collagen type VI alpha 3 chain
ISO
protein:increased expression:serum (human)
RGD
PMID:32245981
RGD:401900121
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
G
Cxcr1
C-X-C motif chemokine receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
mRNA:increased expression:peripheral blood immature plasma cells (human)
RGD
PMID:21087446
RGD:6480657
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
mRNA:increased expression:peripheral blood immature plasma cells (human)
RGD
PMID:21087446
RGD:6480657
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
susceptibility
ISO
DNA:SNPs:multiple (human)
RGD
PMID:28811712
RGD:151665177
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
G
Dap
death-associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
G
Defa5
defensin alpha 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr16:70,342,530...70,344,854
Ensembl chr16:70,342,530...70,344,836
G
Dpep1
dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr19:51,209,831...51,237,004
Ensembl chr19:51,219,660...51,235,257
G
Duox2
dual oxidase 2
ISO
mRNA:increased expression:colon (human)
RGD
PMID:19759286
RGD:40924645
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
G
Ecm1
extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
G
Ephb2
Eph receptor B2
ameliorates
IDA
RGD
PMID:33722292
RGD:127285641
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
G
Esr2
estrogen receptor 2
ISO
mRNA:decreased expression:colon
RGD
PMID:21252046
RGD:5508810
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21593018
RGD:5147754
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fas
Fas cell surface death receptor
treatment
IEP
RGD
PMID:30122878
RGD:13792562
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
treatment
IEP
RGD
PMID:30122878
RGD:13792562
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fcgr2a
Fc gamma receptor 2A
susceptibility
ISO
DNA:polymorphism: :p.A519G (human) DNA:SNP: :rs1801274 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19915573 PMID:20228799 PMID:20848524 PMID:19915573
RGD:5147918 , RGD:5147922
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Fgf7
fibroblast growth factor 7
ISO
mRNA:increased expression:colon, lamina propria, myofibroblasts (human)
RGD
PMID:9358773
RGD:126928145
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Gc
GC, vitamin D binding protein
susceptibility
ISO
DNA:polymorphism:cds:p.T420K(human)
RGD
PMID:21832969
RGD:5509866
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Ghrl
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19617644
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
G
Gna12
G protein subunit alpha 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr12:13,805,580...13,886,255
Ensembl chr12:13,805,698...13,886,255
G
Gpr65
G-protein coupled receptor 65
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30616622
NCBI chr 6:117,515,786...117,536,514
Ensembl chr 6:117,515,648...117,536,512
G
Gpx1
glutathione peroxidase 1
ISO
protein:decreased expression:erythrocyte
RGD
PMID:20186929
RGD:11352754
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
disease_progression
ISO
protein:increased expression:large intestine (human)
RGD
PMID:18479189
RGD:152998902
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:17565649 PMID:26604430 PMID:28626742
RGD:5490554 , RGD:11538341 , RGD:14700999
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:17565649 PMID:26604430
RGD:5490554 , RGD:11538341
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Herc2
HECT and RLD domain containing E3 ubiquitin protein ligase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr 1:106,904,789...107,110,997
Ensembl chr 1:106,880,084...107,108,134
G
Hnf4a
hepatocyte nuclear factor 4, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
G
Hnmt
histamine N-methyltransferase
ISO
RGD
PMID:18340362
RGD:5509777
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
G
Hp
haptoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hspa4
heat shock protein family A (Hsp70) member 4
ISO
protein:increased expression:colon mucosa, epithelium (human)
RGD
PMID:22297444
RGD:5688753
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
G
Htra1
HtrA serine peptidase 1
ISO
protein:decreased expression:colonic epithelium,colonic mucosa (human)
RGD
PMID:28586045
RGD:152985530
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
G
Icam1
intercellular adhesion molecule 1
IEP ISO
mRNA:increased expression:substantia nigra (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15553846 PMID:20584104
RGD:4145388
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Icoslg
inducible T-cell co-stimulator ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr20:10,600,420...10,610,718
Ensembl chr20:10,600,420...10,610,703
G
Igf1r
insulin-like growth factor 1 receptor
ISO
protein:altered expression:colon
RGD
PMID:18938767
RGD:5686432
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Igf2
insulin-like growth factor 2
disease_progression
ISO
RGD
PMID:16088202
RGD:5509966
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Ikzf1
IKAROS family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18836448 PMID:20228799 PMID:28120341 PMID:26660358
RGD:14975153 , RGD:14975255
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il12b
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799 PMID:21297633
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il18rap
interleukin 18 receptor accessory protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
G
Il1b
interleukin 1 beta
IEP ISO
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12133438 PMID:15955209 PMID:20452301 PMID:22119283 PMID:24812904
RGD:10450593
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
G
Il1rn
interleukin 1 receptor antagonist
ISO
DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human)
RGD
PMID:8119534
RGD:6909136
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il23r
interleukin 23 receptor
ISO
DNA:SNP,Haplotype: :rs1884444(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18438406 PMID:19122664 PMID:20228799 PMID:23093364
RGD:8549574
NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
G
Il33
interleukin 33
severity treatment
ISO
mRNA:increased expression:sigmoid colon
RGD
PMID:25112700 PMID:21037074 PMID:28802904
RGD:39938951 , RGD:40813742 , RGD:39938966
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
G
Il7r
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Irf4
interferon regulatory factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38164749
NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
G
Irf5
interferon regulatory factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
G
Irgm
immunity-related GTPase M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Jak2
Janus kinase 2
ISO
DNA:SNP: :rs10758669 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20228799 PMID:21297633 PMID:22269120
RGD:6483020
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kdr
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kif21b
kinesin family member 21B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr13:47,576,129...47,626,112
Ensembl chr13:47,576,160...47,626,127
G
Lamb1
laminin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
G
Lsp1
lymphocyte-specific protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 1:197,614,677...197,648,414
Ensembl chr 1:197,614,687...197,648,416
G
Ltf
lactotransferrin
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16640825 PMID:35999755
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
G
Masp2
MBL associated serine protease 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12904520
NCBI chr 5:159,035,892...159,049,561
Ensembl chr 5:159,035,911...159,049,580
G
Mir155
microRNA 155
ISO
miRNA:decreased expression:feces miRNA:increased expression:colon
RGD
PMID:30927737 PMID:29668922 PMID:29325325 PMID:29438285
RGD:21079443 , RGD:24922213 , RGD:24922207 , RGD:21403682
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir31
microRNA 31
ISO
miRNA:increased expression:colon
RGD
PMID:29438285
RGD:21403682
NCBI chr 5:103,599,038...103,599,143
G
Mmp1
matrix metallopeptidase 1
IDA
RGD
PMID:18837084
RGD:7207395
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22119283
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20380826 PMID:22119283 PMID:24055189
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mst1
macrophage stimulating 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799
NCBI chr 8:108,767,886...108,773,425
Ensembl chr 8:108,768,839...108,773,416
G
Mtrr
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
susceptibility
ISO
DNA:polymorphism: :66A>G (human)
RGD
PMID:21947961
RGD:5508217
NCBI chr 1:34,866,991...34,899,425
Ensembl chr 1:34,867,089...34,899,425
G
Muc2
mucin 2, oligomeric mucus/gel-forming
IEP
mRNA:altered expression: :
RGD
PMID:12870797
RGD:2324685
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
G
Nkx2-3
NK2 homeobox 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405 PMID:18438406 PMID:20228799
NCBI chr 1:242,478,130...242,481,083
Ensembl chr 1:242,478,130...242,481,083
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
Ormdl3
ORMDL sphingolipid biosynthesis regulator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr10:83,590,052...83,596,035
Ensembl chr10:83,590,071...83,598,620
G
Pon1
paraoxonase 1
ISO
mRNA:decreased expression:colon (human)
RGD
PMID:17664137
RGD:5509924
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Pon3
paraoxonase 3
ISO
mRNA:decreased expression:colon (human)
RGD
PMID:17664137
RGD:5509924
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
Prdm1
PR/SET domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
G
Psmg1
proteasome assembly chaperone 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr11:35,276,080...35,285,541
Ensembl chr11:35,276,011...35,285,622
G
Ptger4
prostaglandin E receptor 4
ISO
RGD
PMID:21818367
RGD:6483532
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptgs1
prostaglandin-endoperoxide synthase 1
IMP
RGD
PMID:17429720
RGD:2300267
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP
RGD
PMID:17429720
RGD:2300267
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptpn2
protein tyrosine phosphatase, non-receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15955209
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Ripk2
receptor-interacting serine-threonine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
G
RT1-Bb
RT1 class II, locus Bb
ISO
RGD
PMID:31038770
RGD:14865009
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25559196
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Sell
selectin L
ISO
DNA:polymorphism: :p.F206L (human)
RGD
PMID:19212205
RGD:13464267
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
G
Selp
selectin P
ISO
protein:increased expression:serum
RGD
PMID:21526498
RGD:6218993
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Slc11a1
solute carrier family 11 member 1
ISO
DNA:transition, repeat:promoter:-237C>T (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter (human)
CTD RGD
PMID:16059695 PMID:18340647 PMID:11929588
RGD:5684939 , RGD:5684968
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Slc26a3
solute carrier family 26 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915573
NCBI chr 6:48,023,892...48,064,829
Ensembl chr 6:48,023,892...48,064,772
G
Sphk1
sphingosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
G
Stat3
signal transducer and activator of transcription 3
ISO
DNA:SNP: :rs744166 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18438405 PMID:20228799 PMID:22269120
RGD:6483020
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Thbd
thrombomodulin
ISO
protein:decreased expression:colon, blood vessel
RGD
PMID:17557119
RGD:5685011
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Tnf
tumor necrosis factor
treatment
ISO IEP
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19617644 PMID:20452301 PMID:22119283 PMID:25204186 PMID:24812904 PMID:28120341 More...
RGD:10450577 , RGD:10450593 , RGD:14975153
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
severity
ISO
mRNA,protein:increased expression, decreased expression:colonic mucosa (human)
RGD
PMID:28842689
RGD:151347619
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfsf15
TNF superfamily member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
G
Tp53
tumor protein p53
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15553846
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:plasma, large intestine mucosa
RGD
PMID:19013462
RGD:5684406
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vip
vasoactive intestinal peptide
severity
ISO
mRNA:decreased expression:colon
RGD
PMID:22143367
RGD:5685619
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Vipr1
vasoactive intestinal peptide receptor 1
ISO
RGD
PMID:17611633
RGD:5685618
NCBI chr 8:121,303,739...121,339,587
Ensembl chr 8:121,310,248...121,339,585
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all